SVB Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$27K 494
2025
Q1
$27K Buy
+100
New +$27K ﹤0.01% 691
2023
Q3
Sell
-1,872
Closed -$356K 869
2023
Q2
$356K Buy
1,872
+27
+1% +$5.13K 0.01% 597
2023
Q1
$370K Sell
1,845
-204
-10% -$40.9K 0.01% 642
2022
Q4
$487K Buy
2,049
+128
+7% +$30.4K 0.01% 567
2022
Q3
$384K Buy
1,921
+158
+9% +$31.6K 0.01% 594
2022
Q2
$257K Buy
1,763
+4
+0.2% +$583 ﹤0.01% 611
2022
Q1
$287K Buy
1,759
+6
+0.3% +$979 ﹤0.01% 598
2021
Q4
$297K Sell
1,753
-62
-3% -$10.5K ﹤0.01% 582
2021
Q3
$343K Buy
1,815
+51
+3% +$9.64K ﹤0.01% 727
2021
Q2
$299K Hold
1,764
﹤0.01% 756
2021
Q1
$249K Sell
1,764
-15
-0.8% -$2.12K ﹤0.01% 766
2020
Q4
$231K Hold
1,779
﹤0.01% 703
2020
Q3
$259K Buy
1,779
+15
+0.9% +$2.18K ﹤0.01% 561
2020
Q2
$261K Buy
+1,764
New +$261K ﹤0.01% 488
2020
Q1
Sell
-1,750
Closed -$202K 591
2019
Q4
$202K Buy
+1,750
New +$202K ﹤0.01% 573
2018
Q2
Sell
-1,750
Closed -$208K 444
2018
Q1
$208K Sell
1,750
-100
-5% -$11.9K 0.01% 426
2017
Q4
$235K Sell
1,850
-255
-12% -$32.4K 0.01% 433
2017
Q3
$247K Buy
+2,105
New +$247K 0.01% 417
2016
Q4
Sell
-3,105
Closed -$210K 493
2016
Q3
$210K Sell
3,105
-500
-14% -$33.8K 0.01% 495
2016
Q2
$200K Sell
3,605
-300
-8% -$16.6K 0.01% 489
2016
Q1
$245K Hold
3,905
0.01% 464
2015
Q4
$368K Hold
3,905
0.01% 427
2015
Q3
$314K Hold
3,905
0.01% 462
2015
Q2
$468K Hold
3,905
0.02% 439
2015
Q1
$408K Sell
3,905
-750
-16% -$78.4K 0.01% 441
2014
Q4
$452K Buy
+4,655
New +$452K 0.01% 417